Suppr超能文献

促肠动力药普芦卡必利对禁食大鼠肠道蠕动的影响。

Effect of enterokinetic prucalopride on intestinal motility in fast rats.

作者信息

Qi Hui-Bin, Luo Jin-Yan, Liu Xin

机构信息

Department of Gastroenterology, Second Hospital of Xi'an Jiaotong University, Xi'an 710004, Shannxi Province, China.

出版信息

World J Gastroenterol. 2003 Sep;9(9):2065-7. doi: 10.3748/wjg.v9.i9.2065.

Abstract

AIM

To evaluate the effects of prucalopride on intestinal prokinetic activity in fast rats and to provide experimental basis for clinical treatment of gastrointestinal motility diseases.

METHODS

Gastrointestinal propulsion rate was measured by the migration rate of activated charcoal, which reflexes gastrointestinal motility function. 120 Spraque-Dawley rats were randomly divided into four groups and received an intravenous injection of physiological saline (served as control), prucalopride 1 mg/kg, prucalopride 2 mg/kg and cisapride 1 mg/kg, respectively. The gastrointestinal propulsion rate was measured 1, 2 or 4 hours after intravenous injection of the drugs.

RESULTS

Significant accelerations of gastrointestinal propulsion rate in prucalopride 1 mg/kg and 2 mg/kg groups were found compared with control group at 2 and 4 hours(83.2 %+/-5.5 %, 81.7 %+/-8.5 % vs 70.5 %+/-9.2 %, P<0.01; 91.2 %+/-2.2 %, 91.3 %+/-3.9 % vs 86.8 %+/-2.6 %, P<0.01). The gastrointestinal propulsion rates at 1, 2 or 4 hours were faster in prucalopride 1 mg/kg and 2 mg/kg groups than in cisapride group (84.0 %+/-11.7 %, 77.1 %+/-11.9 % vs 66.3 %+/-13.6 %, P<0.01, P<0.05; 83.2 %+/-5.5 %, 81.7 %+/- 8.5 % vs 75.4 %+/-5.9 %, P<0.01, P<0.05; 91.2 %+/-2.2 %, 91.3 %+/-3.9 % vs 88.6 %+/-3.5 %,P<0.05, P<0.05). No difference of gastrointestinal propulsion rate was found between prucalopride 1 mg/kg group and prucalopride 2 mg/kg group (P>0.05).

CONCLUSION

Prucalopride accelerates intestinal motility in fast rats, and has no dose dependent effect.

摘要

目的

评价普芦卡必利对禁食大鼠肠道促动力活性的影响,为临床治疗胃肠动力性疾病提供实验依据。

方法

采用活性炭移动率测定胃肠推进率,以反映胃肠动力功能。将120只Spraque-Dawley大鼠随机分为四组,分别静脉注射生理盐水(作为对照组)、1 mg/kg普芦卡必利、2 mg/kg普芦卡必利和1 mg/kg西沙必利。在静脉注射药物后1、2或4小时测量胃肠推进率。

结果

与对照组相比,1 mg/kg和2 mg/kg普芦卡必利组在2小时和4小时时胃肠推进率显著加快(83.2%±5.5%,81.7%±8.5%对70.5%±9.2%,P<0.01;91.2%±2.2%,91.3%±3.9%对86.8%±2.6%,P<0.01)。1 mg/kg和2 mg/kg普芦卡必利组在1、2或4小时时的胃肠推进率比西沙必利组更快(84.0%±11.7%,77.1%±11.9%对66.3%±13.6%,P<0.01,P<0.05;83.2%±5.5%,81.7%±8.5%对75.4%±5.9%,P<0.01,P<0.05;91.2%±2.2%,91.3%±3.9%对88.6%±3.5%,P<0.05,P<0.05)。1 mg/kg普芦卡必利组和2 mg/kg普芦卡必利组之间的胃肠推进率无差异(P>0.05)。

结论

普芦卡必利可加快禁食大鼠的肠道蠕动,且无剂量依赖性效应。

相似文献

引用本文的文献

本文引用的文献

4
Slow Transit Constipation.慢传输型便秘
Curr Treat Options Gastroenterol. 2002 Aug;5(4):279-283. doi: 10.1007/s11938-002-0050-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验